Healthcare


 Is Advanced Oncology Research Reshaping Treatment Options?

Is Advanced Oncology Research Reshaping Treatment Options?

March 10, 2025 11:26 PM PDT| By Team Kalkine Media

Highlight,Elevation Oncology (NASDAQ:ELEV) experiences considerable price variation over the past year.,The stock opened at a modest price, showing substantial fluctuation relative to recent highs.,Institutional investors possess a significant portio...

 Is Tenax Therapeutics Set for a New Chapter in Healthcare Innovation?

Is Tenax Therapeutics Set for a New Chapter in Healthcare Innovation?

March 10, 2025 11:20 PM PDT| By Team Kalkine Media

Highlights:,Financial institutions express a favorable view on the company.,Institutional investors are adjusting positions amid dynamic portfolio strategies.,The firm is dedicated to advancing treatments for pulmonary arterial hypertension and chron...

 Are These Small-Cap Medical Innovators Outperforming Their Peers?

Are These Small-Cap Medical Innovators Outperforming Their Peers?

March 10, 2025 10:28 PM PDT| By Team Kalkine Media

Highlights,Quince Therapeutics offers lower volatility with higher institutional and internal stakeholder participation compared to Vaxart.,Vaxart exhibits a broader scope for share price improvement despite unfavorable profitability figures.,Quince...

 Why Is Reddit’s Stock Facing Unstable Market Movements?

Why Is Reddit’s Stock Facing Unstable Market Movements?

March 10, 2025 01:53 PM PDT| By Team Kalkine Media

Why Is Reddit’s Stock Facing Unstable Market Movements?

 Why Are Institutional Investors Increasing Their Holdings in Inspire Medical Systems?

Why Are Institutional Investors Increasing Their Holdings in Inspire Medical Systems?

March 10, 2025 10:09 AM PDT| By Team Kalkine Media

Highlights,Institutional investors have expanded their holdings in Inspire Medical Systems, Inc. , reflecting ongoing interest in the company's market position.,Recent transactions indicate continued engagement from major firms, with acquisitions and...

 Is Zoetis (NYSE:ZTS) Maintaining Its Market Position in the Animal Health Sector?

Is Zoetis (NYSE:ZTS) Maintaining Its Market Position in the Animal Health Sector?

March 10, 2025 09:55 AM PDT| By Team Kalkine Media

Headlines,Zoetis continues to expand its presence in the animal health sector with product innovations.,Recent market movements reflect adjustments in stock evaluations from various firms.,The company remains engaged in strategic initiatives to stren...

 How Is Tarsus Pharmaceuticals (NASDAQ:TARS) Managing Its Product Development Strategy?

How Is Tarsus Pharmaceuticals (NASDAQ:TARS) Managing Its Product Development Strategy?

March 10, 2025 09:55 AM PDT| By Team Kalkine Media

Highlights,Institutional firms have increased their positions in Tarsus Pharmaceuticals, contributing to shifts in market participation.,The company continues to show revenue growth and structured financial management.,Tarsus Pharmaceuticals remains...

 How Has UroGen Pharma (NASDAQ:URGN) Maintained Its Market Position?

How Has UroGen Pharma (NASDAQ:URGN) Maintained Its Market Position?

March 10, 2025 09:36 AM PDT| By Team Kalkine Media

Highlights,Institutional firms have expanded their holdings in UroGen Pharma, with new positions being established.,Company executives adjusted their stock ownership, leading to shifts in internal holdings.,Financial metrics indicate stability, with...

 How Is Walgreens Boots Alliance (NASDAQ:WBA) Gaining Institutional Attention?

How Is Walgreens Boots Alliance (NASDAQ:WBA) Gaining Institutional Attention?

March 10, 2025 09:32 AM PDT| By Team Kalkine Media

Highlights,Oppenheimer & Co. Inc. increased its holdings in Walgreens Boots Alliance, highlighting a shift in investment strategies.,Various institutional firms have adjusted their positions, demonstrating changes in market engagement.,Recent financi...

 Is Nuvectis Pharma (NASDAQ:NVCT) Gaining More Institutional Confidence?

Is Nuvectis Pharma (NASDAQ:NVCT) Gaining More Institutional Confidence?

March 10, 2025 09:30 AM PDT| By Team Kalkine Media

Highlights,Institutional investors increase their holdings in Nuvectis Pharma.,The company advances oncology research with its lead candidate, NXP800.,Market activity reflects ongoing interest in biopharmaceutical innovation.,Institutional Investment...

 Is Institutional Interest in Intellia Therapeutics (NASDAQ:NTLA) on the Rise?

Is Institutional Interest in Intellia Therapeutics (NASDAQ:NTLA) on the Rise?

March 10, 2025 08:45 AM PDT| By Team Kalkine Media

Highlights,Institutional interest grows as firms like Oppenheimer & Co. Inc. and Atria Investments expand their holdings in Intellia Therapeutics.,Company executives adjust stock positions, with recent sales activity reflecting corporate strategies.,...

 Is ADMA Biologics (NASDAQ:ADMA) Becoming a Key Institutional Investment?

Is ADMA Biologics (NASDAQ:ADMA) Becoming a Key Institutional Investment?

March 10, 2025 08:41 AM PDT| By Team Kalkine Media

Highlights,Mutual of America Capital Management LLC expanded its stake in ADMA Biologics by a slight margin during the fourth quarter.,State Street Corp and Geode Capital Management LLC significantly increased their positions in the company.,ADMA Bio...

 How Is Inspire Medical Systems (NYSE:INSP) Expanding Its Market Presence?

How Is Inspire Medical Systems (NYSE:INSP) Expanding Its Market Presence?

March 10, 2025 08:15 AM PDT| By Team Kalkine Media

Highlights,Institutional holdings increase, with Smartleaf Asset Management expanding its position in Inspire Medical Systems.,Investment firms adjust stakes, reflecting broad interest in the company's financial and market performance.,Stock activity...

 How Is Universal Health Services (NYSE:UHS) Strengthening Its Position in Healthcare Services?

How Is Universal Health Services (NYSE:UHS) Strengthening Its Position in Healthcare Services?

March 10, 2025 08:06 AM PDT| By Team Kalkine Media

Highlights,Multiple institutional investors, including Smartleaf Asset Management LLC and Fisher Asset Management LLC, increased their positions in Universal Health Services.,Financial firms have made adjustments in their holdings, reflecting changes...

 Is Walgreens Boots Alliance Navigating Shifts in Healthcare Retail?

Is Walgreens Boots Alliance Navigating Shifts in Healthcare Retail?

March 10, 2025 01:18 AM PDT| By Team Kalkine Media

Highlights:,Mutual of America Capital Management LLC reduced its stake in Walgreens Boots Alliance (NASDAQ:WBA) during the fourth quarter, reflecting broader shifts among hedge funds and institutional investors.,Evaluation reports display mixed persp...

 Is Contineum Therapeutics Shaping Biopharma Innovation?

Is Contineum Therapeutics Shaping Biopharma Innovation?

March 10, 2025 12:28 AM PDT| By Team Kalkine Media

Highlights,Financial institutions have expressed a favorable stance on the company’s performance.,Institutional investment has risen notably during recent trading sessions.,The clinical‐stage entity is advancing its program with the drug candidate PI...

 Can Institutional Shifts Redefine Pharma Performance?

Can Institutional Shifts Redefine Pharma Performance?

March 10, 2025 12:28 AM PDT| By Team Kalkine Media

Highlights,Oppenheimer & Co. Inc. reduced its stake in Teva Pharmaceutical Industries (NYSE:TEVA) during the fourth quarter.,Institutional investors showed varied actions, with FMR LLC and Janus Henderson Group PLC increasing their holdings substanti...

 Is CytomX Pioneering a New Era in Cancer Treatment?

Is CytomX Pioneering a New Era in Cancer Treatment?

March 10, 2025 12:28 AM PDT| By Team Kalkine Media

Highlights:,Company recorded a profit per share when a loss was previously expected.,Quarterly revenue exceeded forecasted figures by a wide margin.,Institutional investor involvement remains robust.,CytomX Therapeutics (NASDAQ:CTMX) operates in the...

 Is Clarivate Plc Steering Strategic Shifts in a Dynamic Sector?

Is Clarivate Plc Steering Strategic Shifts in a Dynamic Sector?

March 10, 2025 12:28 AM PDT| By Team Kalkine Media

Highlights,Institutional investment adjustments observed from prominent financial institutions.,A substantial stock repurchase program has been approved by the board.,Diverse operations span multiple global regions and sectors.,Clarivate Plc (NYSE:CL...

 Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Key Long-Term Outcomes

Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Key Long-Term Outcomes

March 10, 2025 12:10 AM PDT| By Team Kalkine Media

Highlights,Evolut TAVR demonstrated significantly lower rates of bioprosthetic valve dysfunction (BVD) compared to SAPIEN at two years.,Patients treated with Evolut TAVR experienced 5 times less prosthetic valve thrombosis and 9 times less structural...

Recent Articles






Investing Tips

Previous Next